Denmark to stop using J&J vaccine over rare blood clot cases
Nordic country says benefits of Johnson & Johnson vaccine do not outweigh the risk of rare but serious side effect
03 May 2021 - 20:30
Copenhagen — Denmark on Monday became the first country to exclude Johnson & Johnson's (J&J) Covid-19 shots from its vaccination programme over a potential link to a rare but serious form of blood clot.
The move comes after the Nordic country in April stopped using AstraZeneca's vaccine altogether, citing similar concerns...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.